DGKζ-IN-9
DGKζ-IN-9 (compound 73) is a DGKζ inhibitor, with an IC50 ≤200 nM[1].
Product Specifications
CAS Number
3062706-10-6
UNSPSC
12352005
Target
DGK
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Smiles
FC1=CC=C(N(C2=NC(N)=C(C(C3=CC=C(OCC4CC4)C=C3)=O)S2)[C@H](C)C(N)=O)C=C1
Molecular Formula
C23H23FN4O3S
Molecular Weight
454.52
References & Citations
[1]BIOMEDICINE TECHNOLOGY (SHANGHAI) CO., LTD. COMPOUND AS DGKΖ INHIBITOR. Patent WO2024235203.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2012172-01 0.01 mg
Recombinant Ubiquitin Carboxyl Terminal Hydrolase L5 (UCHL5)
Sign In for Pricing
View Details MBS2012172-02 0.05 mg
Recombinant Ubiquitin Carboxyl Terminal Hydrolase L5 (UCHL5)
Sign In for Pricing
View Details MBS2012172-03 0.1 mg
Recombinant Ubiquitin Carboxyl Terminal Hydrolase L5 (UCHL5)
Sign In for Pricing
View Details MBS2012172-04 0.2 mg
Recombinant Ubiquitin Carboxyl Terminal Hydrolase L5 (UCHL5)
Sign In for Pricing
View Details MBS2012172-05 0.5 mg
Recombinant Ubiquitin Carboxyl Terminal Hydrolase L5 (UCHL5)
Sign In for Pricing
View Details MBS2012172-06 1 mg
Recombinant Ubiquitin Carboxyl Terminal Hydrolase L5 (UCHL5)
Sign In for Pricing
View Details